NSG BioLabs and Amgen Launch 2023 Golden Ticket Programme for Biotech Startups

Innovative Startups Can Win One Year of Free Residency and Mentorship from Amgen's Industry Leaders in Fully-equipped Biopolis Laboratory.

NSG BioLabs and Amgen are pleased to announce the launch of the 2023 Amgen Golden Ticket Programme, which is now open for applications. This unique initiative offers innovative biotech startups a chance to win a year of free residency in NSG BioLabs' fully-equipped, certified BSL-2 laboratory and office infrastructure across 22,000 sq ft in Biopolis.

The Amgen Golden Ticket Programme provides participating startups with mentorship from Amgen's network of industry leaders to guide them as they lead their companies. This programme will help startups accelerate their research and development, enabling them to bring their innovative biotech ideas to market sooner.

NSG BioLabs is a leading life science incubator located in the heart of Biopolis, Singapore's biomedical research hub. With access to cutting-edge facilities, startups can conduct research and development in a supportive and collaborative environment, where they can share knowledge and ideas with other like-minded entrepreneurs.

Startups interested in applying for the Amgen Golden Ticket Programme can find more information and apply at nsgtomorrow.com. The application process is straightforward and simple, and the deadline for applications is fast approaching. So, if you're an innovative biotech startup looking for a chance to take your company to the next level, don't miss this opportunity to apply. Scan the QR code below to get started today

Published on : 03rd April, 2023